GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (OTCPK:RDPTF) » Definitions » Pre-Tax Income

Radiopharm Theranostics (Radiopharm Theranostics) Pre-Tax Income : $-31.36 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Radiopharm Theranostics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Radiopharm Theranostics's pretax income for the six months ended in Dec. 2023 was $-16.55 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-31.36 Mil. Radiopharm Theranostics's pretax margin was %.

During the past 2 years, Radiopharm Theranostics's highest Pretax Margin was -11840.07%. The lowest was -336611.11%. And the median was -174225.59%.


Radiopharm Theranostics Pre-Tax Income Historical Data

The historical data trend for Radiopharm Theranostics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Pre-Tax Income Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23
Pre-Tax Income
-21.29 -23.20

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income -12.44 -9.07 -8.44 -14.81 -16.55

Competitive Comparison of Radiopharm Theranostics's Pre-Tax Income

For the Biotechnology subindustry, Radiopharm Theranostics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Radiopharm Theranostics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Pre-Tax Income falls into.



Radiopharm Theranostics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Radiopharm Theranostics's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-23.16+-0.083+-0.058+0.097+0.00099999999999767
=-23.20

Radiopharm Theranostics's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-16.534+-1.043+-0.025+0+1.051
=-16.55

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-31.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radiopharm Theranostics  (OTCPK:RDPTF) Pre-Tax Income Explanation

Radiopharm Theranostics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-16.551/0
=%

During the past 2 years, Radiopharm Theranostics's highest Pretax Margin was -11840.07%. The lowest was -336611.11%. And the median was -174225.59%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radiopharm Theranostics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Radiopharm Theranostics (Radiopharm Theranostics) Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (Radiopharm Theranostics) Headlines

From GuruFocus

RAD adds brain tumor technology to portfolio

By PRNewswire PRNewswire 06-10-2022

RAD adds brain tumor technology to portfolio

By PRNewswire PRNewswire 06-20-2022

PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL

By PRNewswire PRNewswire 10-19-2022

RAD adds brain tumor technology to portfolio

By PRNewswire PRNewswire 07-10-2022

RAD adds brain tumor technology to portfolio

By PRNewswire PRNewswire 06-30-2022